Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Ryan Charles S. Create: Alert

All | News | Filings
Date FiledTypeDescription
12/03/2020 4 Ryan Charles S. (10% Owner) has filed a Form 4 on Neurotrope, Inc.
Txns: Disposed/sold 157,918 options to buy @ $7.55, valued at $1.2M
Disposed/sold 79,097 options to buy @ $4.37, valued at $345.7k
Disposed/sold 150,000 options to buy @ $3.93, valued at $589.5k
Disposed/sold 130,680 options to buy @ $0.7825, valued at $102.3k
Disposed/sold 40,000 options to buy @ $0.972, valued at $38.9k
11/27/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/16/2019 4 Ryan Charles S. (CEO) has filed a Form 4 on Neurotrope, Inc.
Txns: Granted 130,680 options to buy @ $0.7825, valued at $102.3k
05/21/2019 4 Ryan Charles S. (Director) has filed a Form 4 on APPLIED DNA SCIENCES INC
Txns: Granted 175,435 options to buy @ $0.56, valued at $98.2k
03/25/2019 4 Ryan Charles S. (Director) has filed a Form 4 on BioRestorative Therapies, Inc.
Txns: Disposed/sold 15,000 options @ $4.7, valued at $70.5k
Granted 15,000 options @ $0.75, valued at $11.3k
Disposed/sold 20,000 options @ $4.7, valued at $94k
Granted 20,000 options @ $0.75, valued at $15k
Disposed/sold 46,000 options @ $3.73, valued at $171.6k
Granted 46,000 options @ $0.75, valued at $34.5k
Disposed/sold 100,000 options @ $3.35, valued at $335k
Granted 100,000 options @ $0.75, valued at $75k
Disposed/sold 75,000 options @ $1.23, valued at $92.3k
Granted 75,000 options @ $0.75, valued at $56.3k
01/24/2019 4 Ryan Charles S. (CEO) has filed a Form 4 on Neurotrope, Inc.
Txns: Granted 150,000 options to buy @ $3.93, valued at $589.5k
12/17/2018 4 Ryan Charles S. (CEO) has filed a Form 4 on Neurotrope, Inc.
Txns: Granted 79,097 options to buy @ $4.37, valued at $345.7k
10/31/2018 4 Ryan Charles S. (Director) has filed a Form 4 on BioRestorative Therapies, Inc.
Txns: Granted 75,000 options @ $1.23, valued at $92.3k
10/17/2018 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/19/2018 4 Ryan Charles S. (Director) has filed a Form 4 on APPLIED DNA SCIENCES INC
Txns: Granted 63,919 options to buy @ $1.57, valued at $100.4k
Granted 7,204 options to buy @ $1.57, valued at $11.3k
12/18/2017 4 Ryan Charles S. (Director) has filed a Form 4 on Neurotrope, Inc.
Txns: Granted 157,918 options to buy @ $7.55, valued at $1.2M
12/18/2017 3 Ryan Charles S. (Director) has filed a Form 3 on Neurotrope, Inc.
06/29/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
06/26/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
03/03/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
02/16/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
12/22/2016 4 Form 4 - Statement of changes in beneficial ownership of securities
06/14/2016 4 Form 4 - Statement of changes in beneficial ownership of securities

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy